Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Molecular Identification and Characterization of Aminopeptidase N1 From Anopheles Stephensi: A Candidate for Transmission Blocking Vaccines Publisher



Shabani S1, 2 ; Karimi A2, 3 ; Mahboudi F2 ; Poursharif A4 ; Djadid ND2 ; Motalleb G1 ; Raz A2 ; Zakeri S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biology, Faculty of Science, University of Zabol, Iran
  2. 2. Department of Biotechnology, Pasteur Institute of Iran, Iran
  3. 3. Department of Entomology and Vector Control, School of Public Health, Tehran University of Medical Science, Iran
  4. 4. Department of Biology, Faculty of Science, University of Guilan, Iran

Source: Gene Reports Published:2016


Abstract

Malaria is still a serious disease, killing hundreds of thousands of people every year. Previous studies on the Aminopeptidase N1 (APN1) protein from Anopheles gambiae (the main malaria vector in Africa) revealed that it is a receptor for sexual stage of Plasmodium falciparum in midgut of this mosquito and can be inhibited by polyclonal antibodies, producing against the N-terminal of this protein. Despite its importance this gene and its protein have not yet been characterized in Anopheles stephensi (the main malaria vector in Eastern Mediterranean Regions and Indochina). In this paper, total cDNA of APN1 from Anopheles stephensi (APN1As) was identified by using Rapid Amplification of cDNA Ends (RACE), real-time PCR was applied to evaluate amount of mRNA level after blood-feeding, and several bioinformatics tools were used for more characterization of identified sequences. Result showed that this protein has highly similarity that of aminopeptidase N1 from Anopheles gambiae, especially in N-terminal part of this protein. Also, expression level of this gene significantly increases after blood-feeding. Therefore, as this gene and its protein have high similarity that APN1Ag, if biological tests confirm, it could be a candidate for transmission blocking vaccines in malaria endemic countries. © 2016 Elsevier Inc.